INT32707

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.49
First Reported 1987
Last Reported 2007
Negated 2
Speculated 0
Reported most in Body
Documents 2
Total Number 3
Disease Relevance 1.30
Pain Relevance 0.32

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

enzyme regulator activity (Sln)
Anatomy Link Frequency
liver 1
spleen 1
Sln (Mus musculus)
Pain Link Frequency Relevance Heat
Dismenorea 3 91.32 High High
tolerance 2 76.36 Quite High
cva 4 38.72 Quite Low
Parenteral administration 12 5.00 Very Low Very Low Very Low
Bioavailability 12 5.00 Very Low Very Low Very Low
Bile 2 5.00 Very Low Very Low Very Low
transdermal 2 5.00 Very Low Very Low Very Low
Pain 2 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Toxicity 16 100.00 Very High Very High Very High
Cancer 10 98.38 Very High Very High Very High
Sprains And Strains 4 93.72 High High
Dysmenorrhea 3 91.32 High High
Death 2 48.52 Quite Low
Cv General 3 Under Development 4 38.72 Quite Low
Pain 2 5.00 Very Low Very Low Very Low
Influenza Virus Infection 2 5.00 Very Low Very Low Very Low
Acquired Immune Deficiency Syndrome Or Hiv Infection 2 5.00 Very Low Very Low Very Low
Volume Depletion And Dehydration 2 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Cumulative mammary tumour incidences were the highest and the lowest in SHN and C3H/He, respectively, and intermediate in SLN and GR/A.
Positive_regulation (intermediate) of SLN associated with cancer
1) Confidence 0.49 Published 1987 Journal In Vivo Section Abstract Doc Link 2979790 Disease Relevance 1.10 Pain Relevance 0.25
As described, for cetyl palmitate SLN with different surfactants no acute toxicity and no increase in liver and spleen weight was observed.
Neg (no) Positive_regulation (increase) of SLN in spleen associated with toxicity
2) Confidence 0.27 Published 2007 Journal International Journal of Nanomedicine Section Body Doc Link PMC2676808 Disease Relevance 0.10 Pain Relevance 0.04
As described, for cetyl palmitate SLN with different surfactants no acute toxicity and no increase in liver and spleen weight was observed.
Neg (no) Positive_regulation (increase) of SLN in liver associated with toxicity
3) Confidence 0.09 Published 2007 Journal International Journal of Nanomedicine Section Body Doc Link PMC2676808 Disease Relevance 0.10 Pain Relevance 0.04

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox